Skip to main content

BridgeBio Oncology Therapeutics, Inc.

BBOT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001869105

No open-market purchases or sales by BridgeBio Oncology Therapeutics, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $450.6M in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in BridgeBio Oncology Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
65
−2 vs. Q1 2026
Shares held
59.1M
+1.65M (+2.9%) vs. Q1 2026
Total value
$450.6M
−$63.6M (−12.4%) vs. Q1 2026
New holders
16
21 more added
Sold out
18
15 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BBOT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 65 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 42 institutionsQ4 2025: 52 institutionsQ1 2026: 67 institutionsQ2 2026: 65 institutions
Value heldQ2 2026: $450.6M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $657.5MQ4 2025: $724.7MQ1 2026: $514.2MQ2 2026: $450.6M
Institutions holding BBOT and their total value by quarter
QuarterHoldersValue
Q2 202665$450.6M
Q1 202667$514.2M
Q4 202552$724.7M
Q3 202542$657.5M
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding BridgeBio Oncology Therapeutics, Inc.; share changes are against Q1 2026.

Institutions holding BBOT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Cormorant Asset Management, LP17,878,594$136.2M6.98%00.0%Unchanged
Deerfield Management Company, L.P. (Series C)4,885,446$37.2M0.39%00.0%Unchanged
Omega Fund Management, LLC3,289,661$25.1M13.50%00.0%Unchanged
EcoR1 Capital, LLC2,823,126$21.5M1.07%00.0%Unchanged
Alphabet Inc.2,823,126$21.5M0.02%00.0%Unchanged
Wellington Management Group LLP2,789,302$21.3M0.00%−29,046−1.0%Reduced
Enavate Sciences GP, LLC2,626,946$20.0M5.80%00.0%Unchanged
Citadel Advisors LLC2,617,827$19.9M0.01%+89,065+3.5%Added
Novo Holdings A/S2,250,000$17.1M1.00%+64,077+2.9%Added
BlackRock, Inc.2,154,040$16.4M0.00%+65,743+3.1%Added
Vanguard Capital Management LLC2,005,649$15.3M0.00%+1,467,208+272.5%Added
Laurion Capital Management LP2,002,701$15.3M1.11%+80,045+4.2%Added
Armistice Capital, LLC1,764,000$13.4M0.37%+436,000+32.8%Added
State Street Corp1,036,569$7.90M0.00%+810,291+358.1%Added
Aisling Capital Management LP1,018,018$7.76M1.64%00.0%Unchanged
Opaleye Management Inc.700,000$5.33M0.48%+646,718+1,213.8%Added
Geode Capital Management, LLC622,351$4.74M0.00%+43,117+7.4%Added
Granahan Investment Management Inc558,526$4.26M0.15%+327,486+141.7%Added
Sphera Funds Management Ltd.460,985$3.51M0.50%+460,985New
Adage Capital Partners GP, L.L.C.400,000$3.05M0.00%00.0%Unchanged
Royce & Associates LP384,941$2.93M0.02%−251,581−39.5%Reduced
Catalio Capital Management, LP318,407$2.43M0.46%+318,407New
Price T Rowe Associates Inc300,000$2.29M0.00%−137,889−31.5%Reduced
Vanguard Fiduciary Trust Co291,522$2.22M0.00%+37,193+14.6%Added
Charles Schwab Investment Management Inc286,518$2.18M0.00%−4,288−1.5%Reduced
Casdin Capital, LLC282,312$2.15M0.11%00.0%Unchanged
Ensign Peak Advisors, Inc273,530$2.08M0.00%−47,344−14.8%Reduced
Schroder Investment Management Group244,441$1.87M0.00%−4,720−1.9%Reduced
FMR LLC240,587$1.83M0.00%+287+0.1%Added
BNP Paribas Arbitrage, SA191,152$1.46M0.00%+100,333+110.5%Added
Northern Trust Corp186,482$1.42M0.00%+84,224+82.4%Added
Sio Capital Management, LLC130,628$995.4K0.17%00.0%Unchanged
UBS Group AG114,655$873.7K0.00%+64,205+127.3%Added
Millennium Management LLC105,480$803.8K0.00%−160,474−60.3%Reduced
Goldman Sachs Group Inc102,085$777.9K0.00%−65,488−39.1%Reduced
Moore Capital Management, LP100,000$762.0K0.02%00.0%Unchanged
Toroso Investments, LLC93,339$711.2K0.00%+11,167+13.6%Added
Tema ETFs LLC93,339$711.2K0.02%+11,167+13.6%Added
Brevan Howard Capital Management LP88,895$690.7K0.01%+74,647+523.9%Added
Palumbo Wealth Management LLC85,624$652.5K0.14%+85,624New
Bank of America Corp77,140$587.8K0.00%+77,140New
Jump Financial, LLC62,000$472.4K0.00%+62,000New
Renaissance Technologies LLC58,600$446.5K0.00%−43,300−42.5%Reduced
Avidity Partners Management LP43,853$334.2K0.05%−43,853−50.0%Reduced
TD Asset Management Inc42,730$325.6K0.00%−14,842−25.8%Reduced
Virtus Investment Advisers, Inc.42,220$321.7K0.07%+42,220New
Manufacturers Life Insurance Company, The27,984$213.2K0.00%−7,708−21.6%Reduced
Two Sigma Investments, LP26,485$201.8K0.00%+26,485New
Rafferty Asset Management, LLC22,606$172.3K0.00%+22,606New
Citigroup Inc19,872$151.4K0.00%+19,872New
Squarepoint Ops LLC19,662$149.8K0.00%−23,528−54.5%Reduced
Vanguard Global Advisers, LLC18,163$138.4K0.00%00.0%Unchanged
Schonfeld Strategic Advisors LLC11,504$87.7K0.00%+11,504New
Profund Advisors LLC11,001$83.8K0.00%+11,001New
Axq Capital, LP10,728$81.7K0.01%−6,619−38.2%Reduced
Morgan Stanley3,380$25.8K0.00%−39,994−92.2%Reduced
Mirae Asset Global ETFs Holdings Ltd.2,626$20.1K0.00%+2,626New
Barclays PLC2,099$16.0K0.00%+1,887+890.1%Added
Tower Research Capital LLC (TRC)1,696$12.9K0.00%+1,696New
Northwestern Mutual Wealth Management Co1,350$10.3K0.00%+1,350New
Rockefeller Capital Management L.P.1,000$7.62K0.00%+300+42.9%Added
Pacer Advisors, Inc.378$3.00K0.00%+378New
Wells Fargo & Company300$2.29K0.00%00.0%Unchanged
Quarry LP197$1.50K0.00%+197New
Caitong International Asset Management Co., Ltd37$2820.00%+33+825.0%Added
Paradigm Biocapital Advisors LP0$00.00%−868,213−100.0%Sold out
Octagon Capital Advisors LP0$00.00%−719,000−100.0%Sold out
Eventide Asset Management, LLC0$00.00%−541,181−100.0%Sold out
Ikarian Capital, LLC0$00.00%−270,231−100.0%Sold out
Hudson Bay Capital Management LP0$00.00%−110,000−100.0%Sold out
Woodline Partners LP0$00.00%−103,707−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−80,884−100.0%Sold out
HighVista Strategies LLC0$00.00%−78,187−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−71,925−100.0%Sold out
XTX Topco Ltd0$00.00%−59,743−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−48,122−100.0%Sold out
Acadian Asset Management LLC0$00.00%−29,148−100.0%Sold out
Diametric Capital, LP0$00.00%−16,280−100.0%Sold out
Quadrature Capital Ltd0$00.00%−13,351−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−11,793−100.0%Sold out
Bellevue Group AG0$00.00%−6,982−100.0%Sold out
Accent Capital Management, LLC0$00.00%−335−100.0%Sold out
Royal Bank of Canada0$00.00%−154−100.0%Sold out